DeepCurrents Investment Group »

Allogene Therapeutics shares owned by DeepCurrents Investment Group

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by DeepCurrents Investment Group from 13F filings

Historical chart of DeepCurrents Investment Group investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by DeepCurrents Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by DeepCurrents Investment Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $156k 64k 2.44

More positions owned by DeepCurrents Investment Group

Interdigital Note 3.500% 6/0 (Principal)
Netflix Call Option (NFLX)
Strategy Cl A New Put Option (MSTR)
Repligen Corp Note 1.000%12/1 (Principal)
Cloudflare Note 8/1 (Principal)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
Draftkings Note 3/1 (Principal)
Workiva Note 1.250% 8/1 (Principal)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Coinbase Global Note 0.500% 6/0 (Principal)
Strategy Note 0.625% 9/1 (Principal)
Teladoc Health Note 1.250% 6/0 (Principal)
Upwork Note 0.250% 8/1 (Principal)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Snowflake Note 10/0 (Principal)

View all positions for DeepCurrents Investment Group

Top funds holding Allogene Therapeutics

Pfizer
BlackRock
Tpg Gp A
Vanguard Group
PRIMECAP Management Company
Vanguard Capital Management
Citadel Advisors
Two Sigma Investments
Geode Capital Management
Frazier Life Sciences Management
Woodline Partners
Patient Square Capital
Millennium Management
Candriam Luxembourg S.C.A.
Wildcat Capital Management

View all funds holding Allogene Therapeutics